Table 2

Incidence of MetS in group A according to characteristics at baseline

At risk (n)Developing MetS (n)P valueOR (95% CI)Person-yearIncidence per 1000 person-years (95% CI)
All samples1146294 (25.7)864638 (32 to 44)
Gender
 Men419153 (36.5)2.39 (1.82 to 3.13)316648 (41 to 57)
 Women727141 (19.4)0.0001548026 (22 to 30)
Age (years)
 18–4559285 (14.4)1445219 (15 to 24)
 46–60361114 (31.6)2.75 (2.00 to 3.79)273042 (35 to 50)
 61–7517283 (48.3)5.56 (3.82 to 8.11)130564 (51 to 79)
 ≥762112 (57.1)0.0007.95 (3.25 to 19.45)16075 (39 to 131)
Marital status
 Single21839 (17.9)1165024 (17 to 32)
 Married/cohabiting836235 (28.1)1.80 (1.23 to 2.62)629237 (33 to 42)
 Widower4310 (23.3)1.39 (0.63 to 3.06)32731 (15 to 56)
 Divorced4910 (20.4)0.0161.18 (0.54 to 2.56)37827 (13 to 49)
Educational level
 No studies6234 (38.7)3.70 (1.98 to 6.91)47151 (33 to 76)
 Elementary527160 (30.4)2.55 (1.71 to 3.82)397340 (34 to 47)
 Secondary education31675 (23.7)1.82 (1.17 to 2.84)238032 (25 to 40)
 University degree24035 (14.8)0.0001181419 (13 to 27)
Region of the country
 North13526 (19.3)1104025 (16 to 37)
 South447122 (27.3)1.57 (0.98 to 2.53)334137 (30 to 44)
 Centre29185 (29.2)1.73 (1.05 to 2.84)222138 (31 to 47)
 Northeast11726 (22.2)1.20 (0.65 to 2.21)91628 (19 to 42)
 East coast15635 (22.4)0.1351.21 (0.69 to 2.14)112731 (22 to 43)
Number of components of MetS
 029416 (5.4)122197 (4 to 11)
 140172 (18.0)3.80 (2.16 to 6.69)302324 (19 to 30)
 2451206 (45.7)0.00014.61 (8.54 to 24.99)340461 (53 to 69)
Glucose regulation
 Normal885214 (24.2)1667532 (28 to 37)
 >9926180 (30.7)0.0231.39 (1.02 to 1.88)197141 (32 to 51)
HDL-chol low
 No968245 (25.3)1730334 (30 to 38)
 Yes17849 (27.5)0.2961.21 (0.78 to 1.61)134337 (27 to 48)
Central obesity
 No750120 (16.0)1568421 (18 to 25)
 Yes396174 (43.9)0.0004.16 (3.12 to 5.44)296259 (50 to 68)
Hypertension
 No736141 (19.2)1553126 (22 to 30)
 Yes410153 (37.3)0.0002.51 (1.92 to 3.30)311549 (42 to 58)
Hyper-TG
 No1088266 (24.4)1820632 (29 to 37)
 Yes5828 (48.3)0.0002.89 (1.69 to 4.92)44064 (42 to 92)
BMI (kg/m2)
 18–<2547445 (9.5)0.0001358213 (9 to 17)
 25–<30488156 (32.0)4.48 (3.12 to 6.43)368342 (36 to 50)
 >3018291 (50.0)9.53 (6.25 to 14.55)136667 (54 to 82)
IPAQ
 High27869 (24.8)0.9331210333 (26 to 42)
 Moderate38799 (25.6)1.04 (0.73 to 1.49)292134 (28 to 41)
 Low480125 (26.0)1.07 (0.76 to 1.50)361435 (29 to 41)
MET-min/week
 >500777194 (25.0)0.2411332031 (25 to 39)
 ≤500369100 (27.1)1.12 (0.84 to 1.48)277336 (29 to 43)
MEDAS
 <934585 (24.6)0.3301258733 (26 to 41)
 >9801209 (26.1)1.08 (0.81 to 1.45)605935 (30 to 40)
 ≤111095282 (25.8)0.4341.28 (0.58 to 2.18)826634 (30 to 38)
 >115112 (23.5)137931 (16 to 55)
Family history of T2DM
 No528134 (25.4)0.4251394434 (28 to 40)
 Yes595155 (26.1)1.04 (0.79 to 1.35)447635 (29 to 41)
  • Data are n (%).

  • BMI, body mass index; HDL-chol, high-density lipoprotein cholesterol; IPAQ, International Physical Activity Questionnaire; MEDAS, Mediterranean Diet adherence screener; MET, metabolic equivalent of task; MetS, metabolic syndrome; T2DM, type 2 diabetes mellitus; TG, triglyceride.